BAA2023-1 research area 004: development of in vitro diagnostics for biodefense, antimicrobial resistant infections (AMR), and emerging infectious diseases
Active Definitive Contract Awarded Last action
- Contract number
- 75N93024C00051
- Awardee
-
GE Medical Systems Information Technologies, Inc. UEI G2JTZ3UQV9M3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,685,998
Award facts
- Opportunity
-
- 2023 NIAID Omnibus Broad Agency Announcement Solicitation · HHSNIHNIAIDBAA20231 · Posted Jan 11, 2023
- Contract value 69% obligated
-
- $6,685,998.00 Current, with exercised options
- $9,673,642.00 Potential, with all options
- Completion date 42% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Schenectady, NY 12309, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $2,474,025 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $4,211,973 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a definitive contract to GE Medical Systems Information Technologies, Inc. for development of in vitro diagnostics for biodefense, antimicrobial resistant infections, and emerging infectious diseases on September 18, 2024, with a ceiling value of $9.673 million and no set-aside used.
The originating BAA2023-1 Research Area 004 solicitation, posted January 11, 2023 with a due date of April 11, 2023, calls for diagnostic technology development spanning biodefense applications, antimicrobial resistance detection, and emerging infectious disease identification. Place of performance is Schenectady, NY. The contract runs through September 4, 2029 and is structured as cost no fee.
In FY2025, the contract generated $2.1 million in invoiced labor across 8.9 FTEs and 18,458 contractor hours, with a derived government-paid blended hourly rate of $111.79. The prime contractor subcontracted 87 percent of contractor hours to three subcontractors: Rensselaer Polytechnic Institute, The Johns Hopkins University, and Key Technologies Inc.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Rensselaer Polytechnic Institute | $699,797 | |
| The Johns Hopkins University | $1,088,597 | |
| Key Technologies Inc. | $2,290,225 |
Quick answers
Who was awarded contract 75N93024C00051?
75N93024C00051 was awarded to GE Medical Systems Information Technologies, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 18, 2024.
How much is contract 75N93024C00051 worth?
The government has obligated $6,685,998 on 75N93024C00051. Its potential value, with all options, is $9,673,642.
Was contract 75N93024C00051 competed?
The extent of competition for 75N93024C00051 was full and open competition. The government received 10 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award